An interventional study of Power wheelchair soccer in Neuromuscular Diseases and Cerebral Palsy, sponsored by Université Catholique de Louvain. Recruiting at 1 site in Belgium. Open to participants aged 12 Years to 50 Years. Per ClinicalTrials.gov, last updated 2024-02-14.
Sponsored by Université Catholique de Louvain · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 23 studies in Neuromuscular Diseases with a site in Belgium — 7 open to participants now, 11 under way, 3 of them phase 3. Neuromuscular Diseases · Belgium.
Among the 23 studies in Neuromuscular Diseases with a site in Belgium, this one is the 18th largest by planned enrollment of the 20 interventional ones that give a count, is one of 4 that started in 2023, is one of 9 with no phase, reaches primary completion later than 1 of the 10 other live ones, and was the 18th registered.
361 studies on the registry are indexed under Neuromuscular Diseases; 96 are open to participants now.
Browse Neuromuscular Diseases studies →7 of the 23 studies in Neuromuscular Diseases with a site in Belgium are open now. Recruiting first, the newest first:
Avidity Biosciences, Inc. · Sites in Belgium, Australia, Canada and 7 more countries
Ages 7–16 · Men only
Centre Hospitalier Universitaire de Liege · Sites in Belgium
Ages 18+
Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Sites in Belgium
Ages 6–12 · Healthy volunteers
Laurent Servais · Sites in Belgium
Ages 2+ · Healthy volunteers
Universitaire Ziekenhuizen KU Leuven · Sites in Belgium
Ages up to 18
A study can be open while its sites in Belgium have not opened yet or have stopped. Only those recruiting at a site in Belgium →
Of the 69 Neuromuscular Diseases studies recruiting now, 39 (57%) set no upper age limit and 22 (32%) stop at 75 or younger; 35 take children under 18; 16 take healthy volunteers.
This study: 12 Years to 50 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
23 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 4 · Phase 3 8
First in 2006; this study’s year is marked. 4 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 30 across 204 interventional studies indexed under Neuromuscular Diseases.
Median enrollment 77 across the 20 interventional studies, 300 across the 3 observational. Of the 12 that completed or were terminated, 4 (33%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 23 have an industry lead sponsor. The 10 most frequent:
Université Catholique de Louvain is the lead sponsor of 155 studies on the registry; 60 are open to participants now.
Université Catholique de Louvain has 1 study filed under Neuromuscular Diseases — fewer than ten, so there is no comparison to draw.
2 of the studies in Neuromuscular Diseases with a site in Belgium that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06185764Vertex Pharmaceuticals IncorporatedA Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1) | 2027-02-02 |
| NCT07287189Satellos Bioscience, Inc.Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients | 2027-03-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 23 studies in Neuromuscular Diseases with a site in Belgium, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study is a prospective interventional study. It will be conducted at a single center with participants who have neuromotor impairments. The primary objective is to assess and measure the clinical and psychosocial effects of a season of power wheelchair soccer among its participants presenting with severe motor impairments due to neuromuscular lesion.
A maximum of twenty participants will be recruited and included in the same group. Data collection will be performed before, during, and after the wheelchair soccer season. The study will span the entire season, starting in November 2023 and ending in June 2024.
Clinical and psychosocial assessments will be conducted every 3 months. Each assessment session will last 2 hours per participant. Before and after the wheelchair soccer season matches, we will evaluate parameters related to the physical load of the sport. These evaluations will last 10 minutes per participant.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Presenting with towards the practice of an adaptive sport such as power wheelchair soccer.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
soccer game performed with a wheelchair
Other: Power wheelchair soccer
Participants will practice power wheelchair soccer during the course of the power wheelchair soccer season (starting in November 2023 and ending in June 2024). Sessions are given once a week, by a coach with experience in this adaptive sport.
Balance
Balance will be measured using the Trunk control measurement scale. Scores range from 0 to 58, where a higher score displays better trunk control.
Time frame: Throughout the entire study (an average of 8 months)
Balance
Balance will be measured using the Level of sitting scale. Levels range from 1 to 8, where a higher score demonstrates better sitting balance.
Time frame: Throughout the entire study (an average of 8 months)
Balance
Balance will be measured using the function section of the Seated Postural Control measure. Scores range from 12 to 48, where a higher score is attributed to individuals with better postural control.
Time frame: Throughout the entire study (an average of 8 months)
Sensorimotor impairment
Sensorimotor impairment will be measured by the Fugl-Meyer assessment.
Time frame: Throughout the entire study (an average of 8 months)
Hyperactivity of the muscles
Hyperactivity of the muscles will be measured using the Australian Spasticity Assessment scale of the upper-limb main muscle groups. Scores per muscle groups range from 0 to 4, where a higher score represents greater spasticity and more hyperactivity in the muscle group.
Time frame: Throughout the entire study (an average of 8 months)
Hyperactivity of the muscles
Hyperactivity of the muscles will be measured using the Penn Spasm Frequency Scale. Scores range from 0 to 4, where a higher score represents more frequent spasms and hyperactivity of the muscles.
Time frame: Throughout the entire study (an average of 8 months)
Pain
Pain perceived by the participants in their daily life will be measured using the PROMIS pain-pediatric Short Form V2 questionnaire. Scores range from 8 to 40, where a higher score displays more pain in everyday life.
Time frame: Throughout the entire study (an average of 8 months)
Quality of life
Quality of life will be assessed using the KIDSCREEN 27 questionnaire. Scores range from 10 and 50, where 50 represents a very high health-related quality of life.
Time frame: Throughout the entire study (an average of 8 months)
Skills to manage and move power wheelchair
Skills to manage and move power wheelchair will be assessed by the Wheelchair Skills Test Questionnaire version 4.2. Scores range from 0 to 100%, where a greater percentage represents better skills.
Time frame: Throughout the entire study (an average of 8 months)
Social participation
Social participation will be assessed using the Questionnaire of young people's participation.Scores range from 0 to 239, where a higher score displays greater social participation.
Time frame: Throughout the entire study (an average of 8 months)
Autonomy during activities of daily life
Autonomy during activities of daily life will be assessed using the Impact on participation and autonomy questionnaire. A participation score (range: 30-155) and a problem score (0-16) are produced by summing items in each scale. For both, a higher score represent poorer autonomy and more severe difficulty.
Time frame: Throughout the entire study (an average of 8 months)
Strength of the upper-limbs
Strength of the main muscle groups of the upper-limb will be measured using a Microfet 2 dynamometer.
Time frame: Throughout the entire study (an average of 8 months)
Passive range of motion the upper-limbs
Passive range of motion of the upper-limbs will be measured using a goniometer.
Time frame: Throughout the entire study (an average of 8 months)
Body temperature
Body temperature will be evaluated using a tympanic thermometer.
Time frame: Throughout the entire study (an average of 8 months)
Blood oxygen saturation
Blood oxygen saturation will be evaluated using a pulse oximeter.
Time frame: Throughout the entire study (an average of 8 months)
Heart beat rate
Heart beat rate will be evaluated using a heart rate monitor.
Time frame: Throughout the entire study (an average of 8 months)
Blood pressure
Blood pressure will be evaluated on the left upper-arm with a tensiometer. Both systolic and diastolic pressure will be recorded.
Time frame: Throughout the entire study (an average of 8 months)
Satisfaction with the power wheelchair soccer practices
Satisfaction with the power wheelchair soccer practices will be evaluated on a 10 point Likert-scale. A higher score displays greater satisfaction with the practices.
Time frame: Throughout the entire study (an average of 8 months)
Demographic variables
Participants' age, sex, origin of physical impairment, motor impairment severity, hours of physical therapy per week, as well as motor impairment severity, will be collected.
Time frame: Throughout the entire study (an average of 8 months)
Plan to share: No
No publications or documents are linked to this record.
Started Nov 2023 (actual). Primary completion is estimated for Jun 2024, 7 months after the start.
Of 75 non-industry interventional studies with no phase under Neuromuscular Diseases, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 47. This study's planned 7 months is below that.
Counting every sponsor, half of 84 studies reached it within 25 months; a quarter within 12 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Université Catholique de Louvain →